As endocrinologists, we view better treatment as the goal of obesity resear
ch. The ideal obesity treatment would reduce body fat substantially, with p
referential loss from the visceral compartment, and preserve lean tissue wi
th a minimum of side effects. Obesity has been recognized as a chronic dise
ase since 1985. Chronic diseases recognized before obesity may predict the
future of obesity research. Initial treatments of chronic diseases commonly
arise from empirical observations. These observations often stimulate basi
c research into the physiologic mechanisms responsible. Such cross-fertiliz
ation between the clinic and basic science is desirable and expected. As mo
re is learned about the physiology of obesity, treatments can be expected t
o use more downstream mechanisms with less unwanted side effects, the relia
nce on surgical treatments can be expected to decline, and molecular approa
ches are likely to play an increasingly important role. With a better physi
ologic understanding of obesity, advanced clinical endpoints will become mo
re important and molecular approaches are likely to play a more important r
ole in discovery and treatment. Due to the availability of molecular approa
ches, obesity treatment is expected to advance faster than chronic disease
research of the past. Nutrition 2000,16:976-982, (C) Elsevier Science Inc.
2000.